fbpx

OneSight EssilorLuxottica Foundation Fights for Every Child’s ‘Right to See’ this World Sight Day

The OneSight EssilorLuxottica Foundation has created sustainable access to eye care for millions of people in underserved communities. On the occasion of World Sight Day on October 13, EssilorLuxottica and its Foundation will reaffirm their commitment through a multi-pronged awareness campaign titled “The Right to See.” The campaign also includes a series of activations aimed at delivering vision care to those who need it globally.

Today, 2.7 billion people around the world – including an estimated 1 in 3 children – are affected by uncorrected poor vision. The OneSight EssilorLuxottica Foundation aims to accelerate EssilorLuxottica’s mission of helping people “see more, be more,” and its ambition to help eliminate uncorrected poor vision in a generation.

For World Sight Day, the OneSight EssilorLuxottica Foundation partnered with world-renowned American photographer Steve McCurry, who provided the powerful portraits of two children that can be seen across the Foundation’s and EssilorLuxottica’s digital eco-systems. The campaign will be supported across EssilorLuxottica’s portfolio of brands, business units and employee network around the world.

Good vision is a basic human right and existing solutions have the potential to solve 80% of all vision problems in the world,” said Francesco Milleri, Chairman and CEO, and Paul du Saillant, Deputy CEO at EssilorLuxottica. “It is with this conviction and knowledge that we created the OneSight EssilorLuxottica Foundation earlier this year, to accelerate our mission. With “The Right to See,” the Foundation is showing its determination to act as a strong advocate for the vision cause, while delivering on concrete actions to bring vision care to those in need. Together with our 180,000 people, we rally around the Foundation this World Sight Day to become truly one and demonstrate the impact we can have together.”

Click HERE for the full press release.

Featured Posts

LE PARC: Discover the New Fall/Winter Collection 2023

Inspired by art, culture and creative freedom, LE PARC designs vibrant and sophisticated eyewear that highlights the identity of each individual.

Learn More

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa.

Read more

Students and Binocular Vision: The Hidden Obstacle

Two weeks into the start of the school year, young adults returning to the lecture hall are frantically requesting appointments to the office.

Read more

Myopia Profile Enhances its Managing Myopia Reference Guide to Elevate Patient Care

Free Multi-Part Resource Available for Download in 10 Languages

Read more

Registration Now Open for Vision Expo East 2024

The Vision Council and RX announce that registration for Vision Expo East 2024 is officially open.

Read more

LE PARC: Discover the New Fall/Winter Collection 2023

Inspired by art, culture and creative freedom, LE PARC designs vibrant and sophisticated eyewear that highlights the identity of each individual.

Learn More

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa.

Read More

Students and Binocular Vision: The Hidden Obstacle

Two weeks into the start of the school year, young adults returning to the lecture hall are frantically requesting appointments to the office.

Read More

Myopia Profile Enhances its Managing Myopia Reference Guide to Elevate Patient Care

Free Multi-Part Resource Available for Download in 10 Languages

Read More

Registration Now Open for Vision Expo East 2024

The Vision Council and RX announce that registration for Vision Expo East 2024 is officially open.

Read More

LE PARC: Discover the New Fall/Winter Collection 2023

Inspired by art, culture and creative freedom, LE PARC designs vibrant and sophisticated eyewear that highlights the identity of each individual.

Learn More

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa.

Read more

Students and Binocular Vision: The Hidden Obstacle

Two weeks into the start of the school year, young adults returning to the lecture hall are frantically requesting appointments to the office.

Read more

Myopia Profile Enhances its Managing Myopia Reference Guide to Elevate Patient Care

Free Multi-Part Resource Available for Download in 10 Languages

Read more

Registration Now Open for Vision Expo East 2024

The Vision Council and RX announce that registration for Vision Expo East 2024 is officially open.

Read more

LE PARC: Discover the New Fall/Winter Collection 2023

Inspired by art, culture and creative freedom, LE PARC designs vibrant and sophisticated eyewear that highlights the identity of each individual.

Learn More

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa.

Read more

Students and Binocular Vision: The Hidden Obstacle

Two weeks into the start of the school year, young adults returning to the lecture hall are frantically requesting appointments to the office.

Read more

Myopia Profile Enhances its Managing Myopia Reference Guide to Elevate Patient Care

Free Multi-Part Resource Available for Download in 10 Languages

Read more

Registration Now Open for Vision Expo East 2024

The Vision Council and RX announce that registration for Vision Expo East 2024 is officially open.

Read more